Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People who have a close blood relative (such as a parent, child, or biological sibling) who has been diagnosed with multiple myeloma according to international diagnostic standards
- People who understand what the trial involves and are willing to take part in this screening study
- People who are able and willing to attend follow-up appointments and meet the other requirements of the study
Who may not be able to join:
- People who have already been diagnosed with a plasma cell disease, such as MGUS (a condition where abnormal proteins are found in the blood), smoldering myeloma (an early, inactive form of multiple myeloma), or multiple myeloma itself
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Peng Liu, PhD, MD, Fudan University
Phone: +8621-64041990
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The prevalence of monoclonal gammopathy of undetermined significance (MGUS) in MM first-degree relatives; Time to progression (TTP) from MGUS to overt multiple myeloma
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.